Were Craig Gracey’s Omada Health (OMDA) share sales pre-planned under Rule 10b5-1?

Yes. The Form 4 footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. Such plans pre-schedule trades, making the timing more routine and less discretionary.

What is the total share count sold by Omada Health (OMDA) insider Craig Gracey?

The Form 4 shows that Craig Gracey sold a combined 4,167 shares of Omada Health common stock. This includes 2,084 shares sold on June 26, 2026, and 2,083 shares sold on June 29, 2026, through open-market transactions.

Omada Health (OMDA) CAO sells 4,167 shares under 10b5-1 plan

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Omada Health, Inc. Chief Accounting Officer Craig Gracey reported two open-market sales of common stock. On June 26, 2026, she sold 2,084 shares at $20.00 per share, followed by 2,083 shares at $21.00 per share on June 29, 2026, for a total of 4,167 shares sold. These transactions were executed under a Rule 10b5-1 trading plan adopted on March 13, 2026. After the sales, she directly holds 858 shares of Omada Health common stock.

Insider Trade Summary 10b5-1

Net Seller: 4,167 shares ($85,423)

Net Sell 2 txns

Insider Gracey Craig

Role Chief Accounting Officer

Sold 4,167 shs ($85K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,083	$21.00	$44K
Sale	Common Stock	2,084	$20.00	$42K

Holdings After Transaction: Common Stock — 858 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Total shares sold: 4,167 shares First sale size: 2,084 shares First sale price: $20.00 per share +3 more

6 metrics

Total shares sold 4,167 shares Combined open-market sales in June 2026

First sale size 2,084 shares Common stock sold on June 26, 2026

First sale price $20.00 per share Open-market sale on June 26, 2026

Second sale size 2,083 shares Common stock sold on June 29, 2026

Second sale price $21.00 per share Open-market sale on June 29, 2026

Shares held after transactions 858 shares Direct ownership after June 29, 2026 sale

Key Terms

Rule 10b5-1 trading plan, open-market sale, Chief Accounting Officer, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Chief Accounting Officer financial

""officer_title": "Chief Accounting Officer""

A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/30/2026 - 07:09 PM Accepted by SEC EDGAR 06/30/2026 - 07:09 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gracey Craig

(Last)

(First)

(Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO

CALIFORNIA

94080

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/26/2026		S⁽¹⁾		2,084	D	$20	2,941	D
Common Stock	06/29/2026		S⁽¹⁾		2,083	D	$21	858	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

	/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Omada Health (OMDA) report for Craig Gracey?

Omada Health reported that Chief Accounting Officer Craig Gracey sold 4,167 shares of common stock in two open-market transactions. The trades occurred on June 26 and June 29, 2026, as disclosed in a Form 4 insider filing.

At what prices did Omada Health (OMDA) insider Craig Gracey sell shares?

Craig Gracey sold 2,084 Omada Health shares at $20.00 per share on June 26, 2026, and 2,083 shares at $21.00 per share on June 29, 2026. Both transactions were open-market sales reported on Form 4.

How many Omada Health (OMDA) shares does Craig Gracey hold after the Form 4 sales?

Following the reported transactions, Craig Gracey directly holds 858 shares of Omada Health common stock. This post-transaction balance comes after selling a total of 4,167 shares across two open-market trades in late June 2026.